Decreased blood riboflavin levels are correlated with defective expression of RFT2 gene in gastric cancer

doi:10.3748/wjg.v18.i24.3112

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5169)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

482

HTML

4166

Figures (1-3)

282

Tables (1-2)

239

Sum=5169

Jun 28, 2012 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jun 28, 2012; 18(24): 3112-3118
Published online Jun 28, 2012. doi: 10.3748/wjg.v18.i24.3112

Full Size Figure Download Figure

Figure 1 Immunohistochemical staining of gastric lesions using riboflavin transporter 2 gene-specific monoclonal antibodies. A: Expression of riboflavin transporter 2 (RFT2) in normal gastric epithelium with strong staining; B: Moderate expression of RFT2 protein in gastric cancer (GC) tissue; C: Weak expression of RFT2 protein in GC tissue (original magnification, × 400).

Citation: Eli M, Li DS, Zhang WW, Kong B, Du CS, Wumar M, Mamtimin B, Sheyhidin I, Hasim A. Decreased blood riboflavin levels are correlated with defective expression of RFT2 gene in gastric cancer. World J Gastroenterol 2012; 18(24): 3112-3118
URL: https://www.wjgnet.com/1007-9327/full/v18/i24/3112.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i24.3112